Table 3 The related factors of thyroid malignancy by logistic regression model.
Variables | OR | 95%CI | P value | |
|---|---|---|---|---|
Lower | Upper | |||
Overall | ||||
Gender | 0.966 | 0.823 | 1.132 | 0.666 |
Nodule number (single) | 1.185 | 1.015 | 1.383 | 0.031 |
Age | 0.954 | 0.948 | 0.960 | <0.001 |
Body mass index (kg/m 2 ) | ||||
18.5–24 | 1.000 | |||
<18.5 | 1.304 | 1.064 | 1.598 | 0.011 |
24–28 | 0.462 | 0.294 | 0.728 | 0.001 |
≥28 | 1.221 | 1.043 | 1.425 | 0.013 |
Thyroid stimulating hormone | ||||
<0.3 | 1.000 | |||
0.3–1.0 | 1.730 | 1.395 | 2.146 | <0.001 |
1.0–1.9 | 2.465 | 2.000 | 3.037 | <0.001 |
1.9–4.8 | 2.566 | 1.917 | 3.434 | <0.001 |
≥4.8 | 1.527 | 1.122 | 2.080 | 0.007 |
Male patients | ||||
Age | 0.934 | 0.922 | 0.946 | <0.001 |
Nodule number (single) | 1.048 | 0.786 | 1.397 | 0.751 |
Body mass index (kg/m 2 ) | ||||
18.5–24 | 1.000 | |||
<18.5 | 1.632 | 1.122 | 2.376 | 0.010 |
24–28 | 0.956 | 0.183 | 5.000 | 0.958 |
≥28 | 1.342 | 0.959 | 1.879 | 0.086 |
Thyroid stimulating hormone | ||||
<0.3 | 1.755 | 0.938 | 3.284 | 0.078 |
0.3–1.0 | 1.000 | |||
1.0–1.9 | 1.235 | 0.851 | 1.792 | 0.267 |
1.9–4.8 | 1.780 | 1.219 | 2.599 | 0.003 |
≥4.8 | 2.649 | 1.395 | 5.030 | 0.003 |
Female patients | ||||
Age | 0.964 | 0.956 | 0.971 | <0.001 |
Nodule number (single) | 1.208 | 1.001 | 1.447 | 0.039 |
Body mass index (kg/m 2 ) | ||||
18.5–24 | 1.000 | |||
<18.5 | 0.444 | 0.275 | 0.716 | 0.001 |
24–28 | 1.164 | 0.972 | 1.395 | 0.099 |
≥28 | 1.123 | 0.867 | 1.454 | 0.380 |
Thyroid stimulating hormone | ||||
<0.3 | 1.441 | 1.002 | 2.071 | 0.049 |
0.3–1.0 | 1.000 | |||
1.0–1.9 | 2.058 | 1.574 | 2.691 | <0.001 |
1.9–4.8 | 2.824 | 2.188 | 3.645 | <0.001 |
≥4.8 | 2.644 | 1.890 | 3.699 | <0.001 |
